Thalassemia Market Size, Share & Trends Report

Thalassemia Market Size, Share & Trends Analysis Report By Therapeutic Class (Iron Chelating Drugs), By Pipeline (Gene Therapy), By Region (U.S., U.K., France, Germany, Italy, Spain, Japan), And Segment Forecasts, 2016 - 2022

  • Report ID: GVR-2-68038-349-2
  • Number of Pages: 71
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2016
  • Industry: Healthcare

Market Segmentation

  • Thalassemia Therapeutic Class Outlook (Revenue, USD Million, 2016 - 2022)
    • Iron Chelating Drugs
      • Exjade/Jadenu (deferasirox)
  • Thalassemia Pipeline Outlook (Revenue, USD Million, 2016 - 2022)
    • Gene Therapy
      • LentiGlobin
  • Thalassemia Regional Outlook (Revenue, USD Million, 2016 - 2022)
    • The U.S.
      • The U.S. thalassemia market, by therapeutic class
        • Iron Chelating Drugs
          • Exjade/Jadenu (deferasirox)
      • The U.S. thalassemia market, by pipeline
        • Gene Therapy
          • LentiGlobin
    • The U.K.
      • The U.K. thalassemia market, by therapeutic class
        • Iron Chelating Drugs
          • Exjade/Jadenu (deferasirox)
      • The U.K. thalassemia market, by pipeline
        • Gene Therapy
          • LentiGlobin
    • France
      • France thalassemia market, by therapeutic class
        • Iron Chelating Drugs
          • Exjade/Jadenu (deferasirox)
      • France thalassemia market, by pipeline
        • Gene Therapy
          • LentiGlobin
    • Germany
      • Germany thalassemia market, by therapeutic class
        • Iron Chelating Drugs
          • Exjade/Jadenu (deferasirox)
      • Germany thalassemia market, by pipeline
        • Gene Therapy
          • LentiGlobin
    • Italy
      • Italy thalassemia market, by therapeutic class
        • Iron Chelating Drugs
          • Exjade/Jadenu (deferasirox)
      • Italy thalassemia market, by pipeline
        • Gene Therapy
          • LentiGlobin
    • Spain
      • Spain thalassemia market, by therapeutic class
        • Iron Chelating Drugs
          • Exjade/Jadenu (deferasirox)
      • Spain thalassemia market, by pipeline
        • Gene Therapy
          • LentiGlobin
    • Japan
      • Japan thalassemia market, by therapeutic class
        • Iron Chelating Drugs
          • Exjade/Jadenu (deferasirox)
      • Japan thalassemia market, by pipeline
        • Gene Therapy
          • LentiGlobin

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2016 to 2022
  • Market estimates and forecast for product segments up to 2022
  • Regional market size and forecast for product segments up to 2022
  • Market estimates and forecast for application segments up to 2022
  • Regional market size and forecast for application segments up to 2022
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.